BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35588234)

  • 1. Dose of intra-operative opioids has no impact on recurrence or survival in primary liver cancer.
    Zhao L; Teng L; Zhang W; Lin S; Liu X; Dai J; Shao H; Li X; Liu Q; Zou H
    Cancer Med; 2022 Dec; 11(24):4927-4934. PubMed ID: 35588234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The impact of the dosage of intraoperative opioids on postoperative survival outcomes in patients with pancreatic cancer].
    Zhang WH; Liu XJ; Zhao LY; Lin SY; Teng L; Dai JZ; Shao HX; Zou HC
    Zhonghua Yi Xue Za Zhi; 2022 Oct; 102(39):3121-3126. PubMed ID: 36274596
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of Intraoperative Opioid Use on Recurrence-Free and Overall Survival in Patients With Esophageal Adenocarcinoma and Squamous Cell Carcinoma.
    Du KN; Feng L; Newhouse A; Mehta J; Lasala J; Mena GE; Hofstetter WL; Cata JP
    Anesth Analg; 2018 Jul; 127(1):210-216. PubMed ID: 29757780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No association of postoperative opioid usage with long-term surgery outcomes in patients with liver cancer: a population-based retrospective cohort study.
    Yeh PH; Yeh HW; Yang SF; Wang YH; Chou MC; Tsai PK; Yeh CB
    Pain; 2023 Apr; 164(4):848-854. PubMed ID: 36083196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poor oncologic outcomes of hepatocellular carcinoma patients with intra-abdominal infection after hepatectomy.
    Ruan DY; Lin ZX; Li Y; Jiang N; Li X; Wu DH; Wang TT; Chen J; Lin Q; Wu XY
    World J Gastroenterol; 2015 May; 21(18):5598-606. PubMed ID: 25987785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
    Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
    Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term survival after resection of hepatocelluar carcinoma: a potential risk associated with the choice of postoperative analgesia.
    Cao L; Chang Y; Lin W; Zhou J; Tan H; Yuan Y; Zeng W
    Anesth Analg; 2014 Jun; 118(6):1309-16. PubMed ID: 24842178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of Rehepatectomy for Colorectal Liver Metastases: A Contemporary Multi-Institutional Analysis from the French Surgical Association Database.
    Hallet J; Cunha AS; Adam R; Goéré D; Azoulay D; Mabrut JY; Muscari F; Laurent C; Navarro F; Pessaux P;
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):894-903. PubMed ID: 27573524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perioperative blood transfusion does not influence recurrence-free and overall survivals after curative resection for hepatocellular carcinoma: A Propensity Score Matching Analysis.
    Yang T; Lu JH; Lau WY; Zhang TY; Zhang H; Shen YN; Alshebeeb K; Wu MC; Schwartz M; Shen F
    J Hepatol; 2016 Mar; 64(3):583-93. PubMed ID: 26596543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The risk factors for long-term survival outcome in solitary hepatocellular carcinoma up to 2 cm: Propensity score matching analysis in a population cohort with a high rate of HBV infection.
    Wang G; Zhang W; Tan Y; Jiang L; Yang J; Yang J; Yan L
    Int J Surg; 2019 Dec; 72():1-6. PubMed ID: 31610283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perioperative Allogeneic Blood Transfusion Does not Influence Patient Survival After Hepatectomy for Hepatocellular Carcinoma: A Propensity Score Matching Analysis.
    Yamashita YI; Hayashi H; Imai K; Okabe H; Nakagawa S; Kitamura F; Uemura N; Nakao Y; Yusa T; Itoyama R; Yamao T; Umesaki N; Miyata T; Chikamoto A; Shimokawa M; Baba H
    World J Surg; 2019 Nov; 43(11):2894-2901. PubMed ID: 31312946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Surgical treatment of primary liver cancer:a report of 10 966 cases].
    Xia YX; Zhang F; Li XC; Kong LB; Zhang H; Li DH; Cheng F; Pu LY; Zhang CY; Qian XF; Wang P; Wang K; Wu ZS; Lyu L; Rao JH; Wu XF; Yao AH; Shao WY; Fan Y; You W; Dai XZ; Qin JJ; Li MY; Zhu Q; Wang XH
    Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):6-17. PubMed ID: 33412628
    [No Abstract]   [Full Text] [Related]  

  • 13. Does intraoperative and postoperative analgesia cause bile leakage after hepatectomy?
    Igarashi T; Harimoto N; Muranushi R; Yamanaka T; Hagiwara K; Hoshino K; Ishii N; Tsukagoshi M; Watanabe A; Kubo N; Araki K; Saito S; Shirabe K
    Surg Today; 2022 Apr; 52(4):690-696. PubMed ID: 34542715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perioperative analgesia with parecoxib sodium improves postoperative pain and immune function in patients undergoing hepatectomy for hepatocellular carcinoma.
    Wang RD; Zhu JY; Zhu Y; Ge YS; Xu GL; Jia WD
    J Eval Clin Pract; 2020 Jun; 26(3):992-1000. PubMed ID: 31407484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nomogram for preoperative estimation of long-term survival of patients who underwent curative resection with hepatocellular carcinoma beyond Barcelona clinic liver cancer stage A1.
    Ruan DY; Lin ZX; Wang TT; Zhao H; Wu DH; Chen J; Dong M; Lin Q; Wu XY; Li Y
    Oncotarget; 2016 Sep; 7(38):61378-61389. PubMed ID: 27542216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeat hepatectomy for patients with early and late recurrence of hepatocellular carcinoma: A multicenter propensity score matching analysis.
    Xing H; Sun LY; Yan WT; Quan B; Liang L; Li C; Zhou YH; Wang H; Zhong JH; Gu WM; Chen TH; Wang MD; Wu H; Pawlik TM; Lau WY; Wu MC; Shen F; Yang T
    Surgery; 2021 Apr; 169(4):911-920. PubMed ID: 31879090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
    Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
    World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors of disease-free and overall survival in patients with hepatocellular carcinoma undergoing partial hepatectomy in curative intent.
    Lurje G; Bednarsch J; Czigany Z; Amygdalos I; Meister F; Schöning W; Ulmer TF; Foerster M; Dejong C; Neumann UP
    Langenbecks Arch Surg; 2018 Nov; 403(7):851-861. PubMed ID: 30267147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perioperative blood transfusion has distinct postsurgical oncologic impact on patients with different stage of hepatocellular carcinoma.
    Chen GX; Qi CY; Hu WJ; Wang XH; Hua YP; Kuang M; Peng BG; Li SQ
    BMC Cancer; 2020 May; 20(1):487. PubMed ID: 32471389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel prognostic nomogram for colorectal cancer liver metastasis patients with recurrence after hepatectomy.
    Liang JY; Lin HC; Liu J; Wang DS; Yuan YF; Li BK; Zheng Y; Wu XJ; Chen G; Wang FH; Wang ZQ; Pan ZZ; Wan DS; Xu RH; Li YH
    Cancer Med; 2021 Mar; 10(5):1535-1544. PubMed ID: 33539664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.